Kripps Caffeine
Natural health product licensed in Canada
- Licence holder
- Kripps Pharmacy Ltd.
- NPN or DIN-HM
- 80003976
- Status
- Inactive licence
- Licence date
- 31 August 2007
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Caféine | 100 mg | Not calculated |
Non-medicinal ingredients
cellulose, Phosphate de calcium, dibasique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Helps temporarily to promote alertness and wakefulness, and to enhance cognitive performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have high blood pressure, glaucoma and/or detrusor instability (overactive bladder syndrome). For a dose >300 mg per day, consult a heath care practitioner if you are of childbearing age, pregnant or breastfeeding. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs which increase blood pressure is not recommended. Consult a health care practitioner prior to use if you are taking lithium. Consumption with other caffeine containing products (e.g. Medications, coffee, tea, colas, cocoa, guarana, maté) is not remmended. This product is not intended as a substitute for sleeping.
- Effets indésirables connus
At a dose >600 mg per day, caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache. Hypersensitivity/allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80003976
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.